BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 8695846)

  • 1. Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow.
    Debili N; Coulombel L; Croisille L; Katz A; Guichard J; Breton-Gorius J; Vainchenker W
    Blood; 1996 Aug; 88(4):1284-96. PubMed ID: 8695846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the cellular mechanisms of erythropoietin-thrombopoietin synergy.
    Papayannopoulou T; Brice M; Farrer D; Kaushansky K
    Exp Hematol; 1996 Apr; 24(5):660-9. PubMed ID: 8605971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the human burst-forming unit-megakaryocyte.
    Briddell RA; Brandt JE; Straneva JE; Srour EF; Hoffman R
    Blood; 1989 Jul; 74(1):145-51. PubMed ID: 2473794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro growth of human fetal CD34+ cells in the presence of various combinations of recombinant cytokines under serum-free culture conditions.
    Zauli G; Vitale M; Visani G; Marchisio M; Milani D; Capitani S
    Br J Haematol; 1994 Mar; 86(3):461-7. PubMed ID: 7519034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast cell growth factor (c-kit ligand) supports the growth of human multipotential progenitor cells with a high replating potential.
    Carow CE; Hangoc G; Cooper SH; Williams DE; Broxmeyer HE
    Blood; 1991 Nov; 78(9):2216-21. PubMed ID: 1718490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells.
    Terstappen LW; Huang S; Safford M; Lansdorp PM; Loken MR
    Blood; 1991 Mar; 77(6):1218-27. PubMed ID: 1705833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of early hematopoiesis in serum-deprived cultures of mafosfamide-treated and untreated CD34-enriched bone marrow cells.
    Ottmann OG; Stella CC; Eder M; Reutzel P; Ströcker S; Hoelzer D; Ganser A
    Exp Hematol; 1991 Sep; 19(8):773-8. PubMed ID: 1714403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of a primitive megakaryocyte progenitor cell in human fetal bone marrow.
    Bruno E; Murray LJ; DiGiusto R; Mandich D; Tsukamoto A; Hoffman R
    Exp Hematol; 1996 Mar; 24(4):552-8. PubMed ID: 8608806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressive effects of TNF-alpha, TGF-beta1, and chemokines on megakaryocytic colony formation in CD34+ cells derived from umbilical cord blood compared with mobilized peripheral blood and bone marrow.
    Lu L; Wang LS; Cooper RJ; Liu HJ; Turner K; Weich N; Broxmeyer HE
    J Hematother Stem Cell Res; 2000 Apr; 9(2):195-204. PubMed ID: 10813532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porcine brain microvascular endothelial cells support the in vitro expansion of human primitive hematopoietic bone marrow progenitor cells with a high replating potential: requirement for cell-to-cell interactions and colony-stimulating factors.
    Davis TA; Robinson DH; Lee KP; Kessler SW
    Blood; 1995 Apr; 85(7):1751-61. PubMed ID: 7535587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A murine stromal cell line allows the proliferation of very primitive human CD34++/CD38- progenitor cells in long-term cultures and semisolid assays.
    Issaad C; Croisille L; Katz A; Vainchenker W; Coulombel L
    Blood; 1993 Jun; 81(11):2916-24. PubMed ID: 7684620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine prolactin-like protein E synergizes with human thrombopoietin to stimulate expansion of human megakaryocytes and their precursors.
    Lefebvre P; Lin J; Linzer DI; Cohen I
    Exp Hematol; 2001 Jan; 29(1):51-8. PubMed ID: 11164105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal human bone marrow CD34(+)CD133(+) cells contain primitive cells able to produce different categories of colony-forming unit megakaryocytes in vitro.
    Charrier S; Boiret N; Fouassier M; Berger J; Rapatel C; Pigeon P; Mareynat G; Bonhomme J; Camilleri L; Berger MG
    Exp Hematol; 2002 Sep; 30(9):1051-60. PubMed ID: 12225797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cell growth factor modulates CD36 antigen expression on erythroid progenitors from human bone marrow and peripheral blood associated with ongoing differentiation.
    de Wolf JT; Muller EW; Hendriks DH; Halie RM; Vellenga E
    Blood; 1994 Jul; 84(1):59-64. PubMed ID: 7517219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD109 is expressed on a subpopulation of CD34+ cells enriched in hematopoietic stem and progenitor cells.
    Murray LJ; Bruno E; Uchida N; Hoffman R; Nayar R; Yeo EL; Schuh AC; Sutherland DR
    Exp Hematol; 1999 Aug; 27(8):1282-94. PubMed ID: 10428505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34+CD38- bone marrow cells with multilineage potential at the single-cell level: key role of thrombopoietin.
    Borge OJ; Ramsfjell V; Cui L; Jacobsen SE
    Blood; 1997 Sep; 90(6):2282-92. PubMed ID: 9310479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.